Glycosylated hemoglobin level and number of oral antidiabetic drugs predict whether or not glycemic target is achieved in insulin-requiring type 2 diabetes
Author:
Funder
Sanofi Taiwan Co., Ltd
Publisher
Elsevier BV
Subject
Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine,Family Practice
Reference38 articles.
1. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study;Stratton;BMJ,2000
2. Standards of medical care in diabetes – 2013;American Diabetes Association;Diabetes Care,2013
3. Racial/ethnic- and education-related disparities in the control of risk factors for cardiovascular disease among individuals with diabetes;Chatterji;Diabetes Care,2012
4. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group;Turner;JAMA,1999
5. Multiple HbA1c targets and insulin analogues in type 2 diabetes: a systematic review;Giugliano;J. Diabetes Complications,2011
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Sex differences in type 2 diabetes: an opportunity for personalized medicine;Biology of Sex Differences;2023-12-13
2. The application of multivariate adaptive regression splines in exploring the influencing factors and predicting the prevalence of HbA1c improvement;Annals of Palliative Medicine;2021-02
3. Clinical outcomes of basal insulin and oral antidiabetic agents as an add-on to dual therapy in patients with type 2 diabetes mellitus;Scientific Reports;2020-04-01
4. The Status of Metabolic Control in Patients With Type 2 Diabetes Attending Dasman Diabetes Institute, Kuwait;Frontiers in Endocrinology;2019-06-26
5. Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%;Diabetes, Obesity and Metabolism;2019-01-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3